2 Einträge gefunden

1. Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial:The XATOA Registry

   1. Fox, Keith A A
   2. Aboyans, Victor
   3. Debus, E Sebastian
   4. Zeymer, Uwe
   5. Cowie, Martin R
   6. Patel, Manesh
   7. Welsh, Robert C

   2022 - Forschungsinformationssystem des UKE
2. Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both

   1. Fox, Keith A A
   2. Anand, Sonia S
   3. Aboyans, Victor
   4. Cowie, Martin R
   5. Debus, E Sebastian
   6. Zeymer, Uwe
   7. Monje, Danja

   2020 - Forschungsinformationssystem des UKE